Larson Financial Group’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79 Hold
37
– – ﹤0.01% 3759
2026
Q2
$113 Sell
37
-30
-45% -$77 ﹤0.01% 3645
2026
Q1
$187 Buy
67
+51
+319% +$173 ﹤0.01% 3460
2025
Q4
$59 Buy
+16
New +$46 ﹤0.01% 3372

Other funds holding FBIO

Larson Financial Group's FBIO Position: Q3 2026 in Review

Larson Financial Group held its Fortress Biotech (FBIO) position steady in Q3 2026 at 37 shares worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

Larson Financial Group first reported a position in FBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $187 in Q1 2026. 60 funds tracked by Wall St. Rank hold FBIO as of Q3 2026.

  • Larson Financial Group held 37 shares of Fortress Biotech worth $79 as of Q3 2026.
  • Larson Financial Group left its Fortress Biotech share count unchanged in Q3 2026.
  • Fortress Biotech made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3759 holding.
  • Larson Financial Group first reported a position in Fortress Biotech in Q4 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Fortress Biotech position peaked at $187 in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.